Supplementing Hearing Aids With Computerized Auditory Training

NCT ID: NCT00727337

Last Updated: 2018-07-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

279 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed to examine the effectiveness of a computer-based auditory training program to improve the benefits received by individuals who wear hearing aids. The study will involve 3 groups - a computer-based training group, an active listening group which will involve listening to books on CD, and a placebo group that receives no additional treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This proposed study is a multi-site, single-masked (blinded), randomized controlled, parallel group clinical trial to assess the effectiveness of an at home PC-based auditory training as a supplement to standard-of-care hearing-aid intervention in veterans treated for hearing loss, with or without previous hearing-aid experience. The participants will be assigned randomly to one of three groups, with hearing-aid use stratified within the groups: (1) Group 1, HA+AT, in which the participants will receive standard-of-care hearing-aid intervention (HA) and complete the four-week LACE auditory training program (AT); (2) Group 2, HA, with the participants receiving only standard-of-care hearing-aid intervention (HA); and (3) Group 3, HA+DL, in which the participants will receive standard-of-care hearing-aid intervention (HA) and complete four-weeks of placebo auditory training, consisting of directed listening (DL) to books-on-tape. The participants in each group will attend four test sessions. During Session 1 the informed consent process will be completed, baseline assessments will be made to ensure that the participants meet the study inclusion criteria (page 52), testing of predictor variables (page 57-58) will be completed, and all hearing aids will be assessed for correct functionality (page 53). The participants then will be assigned randomly to a study group. Session 2 will occur four weeks after Session 1. During Session 2, baseline performance on the outcome measures will be assessed (page 54-57), as will performance on the predictor variables. Following testing, the participants in Groups 1 and 3 will receive training in the use of the AT or DL programs. Session 3 will occur at the end of the 4-week experimental training period. During Session 3 all participants will be retested on the outcome measures to assess short-term intervention outcomes. During Session 4, which will occur at seven-months post-study enrollment (i.e., six-months post training completion for Groups 1 and 3), all participants will be retested on all outcome measures to examine the long-term outcomes. In Sessions 2-4, the stability of hearing-aid function will be assessed through electroacoustic measures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LACE-DVD

Participants will complete the LACE training, however, not in an interactive computer mode but through a static DVD mode

Group Type EXPERIMENTAL

Lace-DVD

Intervention Type BEHAVIORAL

DVD based Auditory Training

LACE-COMPUTER

Participants will complete a computer-based auditory training program (i.e., LACE)

Group Type EXPERIMENTAL

LACE-computer

Intervention Type BEHAVIORAL

Computerized Auditory Training

PLACEBO-DIRECTED LISTENING

Participants will complete a directed listening to books on CD treatment

Group Type ACTIVE_COMPARATOR

PLACEBO-Directed listening

Intervention Type BEHAVIORAL

Subjects will be asked to listen to books on tape for 20 minutes a day and answer questions as they go along

CONTROL

Participants will be provided with hearing aids

Group Type ACTIVE_COMPARATOR

CONTROL

Intervention Type BEHAVIORAL

No specialized treatment will be provided in addition to standard of care audiology treatment provided with the provision of hearing aids

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LACE-computer

Computerized Auditory Training

Intervention Type BEHAVIORAL

PLACEBO-Directed listening

Subjects will be asked to listen to books on tape for 20 minutes a day and answer questions as they go along

Intervention Type BEHAVIORAL

CONTROL

No specialized treatment will be provided in addition to standard of care audiology treatment provided with the provision of hearing aids

Intervention Type BEHAVIORAL

Lace-DVD

DVD based Auditory Training

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. adult onset hearing loss,
2. English as the first language,
3. bilateral, symmetric, sensorineural hearing loss,
4. average audiometric thresholds for 500, 1000, and 2000 Hz less than 50-dB HL in either ear,
5. aided speech recognition in quiet of 40% binaurally,
6. appropriate cognitive skills assessed using the Mini Mental State Exam (Folstein et al., 1975) with age/education norms (Crum et al., 1993),
7. adequate vision to participate in the study as determined with the Smith-Kettlewell Institute Low Luminance (SKILL) Card,
8. eligible for VA-issued hearing aids.

Exclusion Criteria

known neurological, psychiatric disorders, or co-morbid diseases that would prevent completion of the study as determined by chart review,
Minimum Eligible Age

55 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Theresa Chisolm, PhD

Role: PRINCIPAL_INVESTIGATOR

University of South Florida

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA Medical Center, Bay Pines

Bay Pines, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Chisolm TH, Saunders GH, Frederick MT, McArdle RA, Smith SL, Wilson RH. Learning to listen again: the role of compliance in auditory training for adults with hearing loss. Am J Audiol. 2013 Dec;22(2):339-42. doi: 10.1044/1059-0889(2013/12-0081).

Reference Type BACKGROUND
PMID: 24018575 (View on PubMed)

Saunders GH, Smith SL, Chisolm TH, Frederick MT, McArdle RA, Wilson RH. A Randomized Control Trial: Supplementing Hearing Aid Use with Listening and Communication Enhancement (LACE) Auditory Training. Ear Hear. 2016 Jul-Aug;37(4):381-96. doi: 10.1097/AUD.0000000000000283.

Reference Type RESULT
PMID: 26901263 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C6303-R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hearing Aids and the Brain
NCT03279510 COMPLETED NA
Evaluation of Hearing Aid Benefit
NCT05198713 COMPLETED NA